Chardan Capital Downgrades Moderna to Neutral, Raises Price Target to $191

Chardan Capital analyst Geulah Livshits downgrades Moderna (NASDAQ:MRNA) from Buy to Neutral and raises the price target from $186 to $191.

byBenzinga Newsdesk

December 14, 2022

1 minute read

Chardan Capital analyst Geulah Livshits downgrades Moderna (NASDAQ:MRNA) from Buy to Neutral and raises the price target from $186 to $191.

Chardan Capital Maintains Buy on Arrowhead Pharmaceuticals, Lowers Price Target to $94

By Benzinga Newsdesk

Today, 11:31 PM

Chardan Capital analyst Keay Nakae maintains Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Buy and lowers the price target from $97 to $94.

ARWR

FedEx Cargo Plane And Southwest Airlines Passenger Flight In A Potential Collision Call At Texas Airport, Safety Board Investigates

By Vandana Singh

Today, 11:31 PM

FedEx Corp (NYSE: FDX) cargo plane coming to land at a Texas airport could have collided with Southwest Airlines Co's (NYSE: LUV) passenger jet was taking off using the same runway.

Tesla Analyst Flags 2 Features That Prove Using FSD Is Safer Than Driving Without It

By Shanthi Rexaline

Today, 11:31 PM

Tesla Inc.’s (NASDAQ: TSLA) full-self driving beta, which got a wider launch earlier this month, is touted as a key revenue oppo

TSLA

Robert Half International Q2 EPS $1.60 Beats $1.59 Estimate, Sales $1.86B Miss $1.90B Estimate

By Benzinga Newsdesk

Today, 11:31 PM

Robert Half International (NYSE:RHI) reported quarterly earnings of $1.60 per share which beat the analyst consensus estimate of $1.59 by 0.63 percent. This is a 20.3 percent increase over earnings of $1.33 per share

RHI

Chardan Capital Downgrades Moderna to Neutral, Raises Price Target to $191

Related Posts

Chardan Capital Maintains Buy on Arrowhead Pharmaceuticals, Lowers Price Target to $94

FedEx Cargo Plane And Southwest Airlines Passenger Flight In A Potential Collision Call At Texas Airport, Safety Board Investigates

Tesla Analyst Flags 2 Features That Prove Using FSD Is Safer Than Driving Without It

Robert Half International Q2 EPS $1.60 Beats $1.59 Estimate, Sales $1.86B Miss $1.90B Estimate